Three Years of Infertility: Choosing the Right Assisted Technique
Sunita, 33, and Rakesh, 38, have been trying to conceive for three years. Sunita's cycles are irregular, ranging from 35 to 50 days, and an ultrasound shows polycystic ovaries with an anti-Mullerian hormone level of 7.8 ng/mL. A hysterosalpingogram reports that both fallopian tubes are blocked in the ampullary region and that the uterine cavity is normal. Rakesh's semen analysis gives a volume of 3.0 mL, a concentration of 55 million spermatozoa per mL, progressive motility of 25% and 5% normal morphology. Sunita's FSH is 5.2 mIU/mL; her thyroid profile and prolactin are normal. Rakesh has no varicocele and no history of genital infection. The clinic counsellor lists intrauterine insemination (IUI), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT) and in-vitro fertilisation with embryo transfer (IVF-ET) as the options and asks the couple to choose. Rakesh is worried about the cost and about twins, and asks whether one attempt of the cheapest option would be enough.
1. Which of the four listed procedures can work for this couple, and why are the other three unsuitable?
Read the worked answer
Step 1 - what each technique requires. IUI places washed sperm into the uterine cavity and then depends on the fallopian tube to pick up the oocyte and host fertilisation; at least one patent, functional tube is essential. GIFT transfers oocytes plus sperm into the fimbrial end of the tube, and ZIFT transfers a zygote into the tube, so both also require healthy tubes.
Step 2 - apply the findings. The hysterosalpingogram shows bilateral ampullary blockage, so IUI, GIFT and ZIFT are all mechanically impossible: the gametes cannot meet.
Step 3 - what IVF-ET does differently. Controlled ovarian stimulation (gonadotropin with a GnRH antagonist, because of the polycystic ovaries), an hCG trigger when the leading follicles are mature, transvaginal ultrasound-guided oocyte retrieval, fertilisation in culture, and transfer of a cleavage-stage embryo (about day 3) or a blastocyst (day 5) directly into the uterine cavity - the tube is bypassed entirely.
Answer: IVF-ET. The high AMH of 7.8 ng/mL and the polycystic ovaries mean a genuine ovarian hyperstimulation risk, so a low starting dose, careful oestradiol and follicle monitoring, and consideration of freezing all embryos belong to the same decision, not to a later one.
2. Rakesh's sperm concentration is normal but progressive motility is 25%. Should the embryologist plan ICSI for this cycle?
Read the worked answer
Compare each value with its reference limit. A concentration of 55 million/mL is well above the lower reference limit of about 15 million/mL, so this is not oligozoospermia. Progressive motility of 25% is only modestly below the reference value of about 32%, and 5% normal forms is just above the 4% threshold. Taken together this is mild male factor, not severe male factor.
When ICSI is clearly justified. Very low counts (roughly under 5 million/mL), near-zero motility, normal morphology near 0-1%, previous total or near-total failure of fertilisation, surgically retrieved or frozen-thawed testicular sperm, or high anti-sperm antibodies. None of these applies here.
The judgement call. Standard IVF insemination is likely to succeed and avoids the extra cost and the theoretical risk of bypassing natural sperm selection. A sensible compromise is to inseminate most oocytes by standard IVF and keep a proportion for rescue ICSI if fertilisation is below about 30% at the 16-18 hour check. Because a single semen sample is not reliable, a repeat analysis and a semen culture before the cycle is also part of the decision.
3. Why does the counsellor insist on transferring only one or two embryos, and what should Sunita be told about the risks of stimulation?
Read the worked answer
The embryo-number argument. For a woman of 33 with good-quality embryos, each transferred embryo carries roughly a 30-40% chance of implanting. Transferring two raises the chance that at least one implants, but it also multiplies the chance of twins. Twins mean preterm delivery, low birth weight, neonatal intensive care, gestational diabetes and pre-eclampsia; the extra cost of a twin pregnancy is far larger than the cost of one more frozen transfer. If a good-quality blastocyst is available, elective single embryo transfer with vitrification of the rest is the better plan; two embryos are reserved for poorer prognosis.
The stimulation argument. With polycystic ovaries and AMH 7.8 ng/mL the ovaries are highly responsive, so the risk of ovarian hyperstimulation syndrome is real and can be late-onset, driven by pregnancy hCG. Mitigation: a low gonadotropin dose, an antagonist protocol, cautious trigger choice (agonist trigger with freeze-all where appropriate), and monitoring of oestradiol, follicle number and haematocrit. She must be told to report bloating, reduced urine output and breathlessness immediately.
Cost reasoning. Planned single fresh transfer followed by frozen transfers gives a lower cost per live birth than repeated double transfers, which is the answer to Rakesh's question about cost and twins.